Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8653532 | Annals of Vascular Surgery | 2018 | 10 Pages |
Abstract
Preoperative statin and antiplatelet use in patients undergoing CEA was more often observed in patients with higher rates of comorbidities and asymptomatic disease, and this may represent closer follow-up and engagement with primary care physicians in this patient cohort. Preoperative statin and antiplatelet use did not affect perioperative outcomes suggesting that its short-term use is not essential. In patients who are not on statins or antiplatelet medications, CEA can safely be performed before consideration is given to their initiation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Brianna M. Krafcik, Alik Farber, Robert T. Eberhardt, Jeffrey A. Kalish, Denis Rybin, Gheorghe Doros, Steven L. Pike, Jeffrey J. Siracuse,